Fat Distribution among Children Born Extremely Low Birth Weight and Very Low Birth Weight: A Cohort Study

Susi Araújo Alves1, Emanuela Virginia Cavalcante1, Narjara Tiane Melo1

  • 1Department of Pediatrics, Faculdade Pernambucana de Saúde (FPS), Recife, Brazil.

Childhood Obesity (Print)
|October 16, 2020
PubMed

Insights

Children born extremely low birth weight (ELBW) have significantly higher visceral fat thickness compared to those born very low birth weight (VLBW). This difference in fat distribution persists into childhood, impacting long-term health outcomes.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Developmental Biology

Background:

  • Fat distribution is linked to chronic disease development.
  • Birth weight is a critical factor influencing lifelong fat distribution patterns.
  • Understanding early-life influences on adiposity is crucial for preventative health strategies.

Purpose of the Study:

  • To compare abdominal fat distribution in children born extremely low birth weight (ELBW) versus very low birth weight (VLBW).
  • To investigate the impact of birth weight classification on visceral and subcutaneous fat thickness in early childhood.

Main Methods:

  • Retrospective cohort study design.
  • Inclusion of children around their 7th year of life.
  • Assessment of abdominal subcutaneous and visceral fat thickness using ultrasonography.
  • Statistical analysis via multiple linear regression.

Main Results:

  • Children born ELBW exhibited significantly increased visceral fat thickness compared to those born VLBW (3.13 mm vs. 1.86 mm).
  • Subcutaneous fat thickness did not differ significantly between the ELBW and VLBW groups.
  • The observed difference in visceral fat remained significant after adjusting for age, gender, and BMI.

Conclusions:

  • Extremely low birth weight (ELBW) is associated with increased visceral adiposity in childhood compared to very low birth weight (VLBW).
  • Altered fat distribution, specifically higher visceral fat, in ELBW survivors may have long-term implications for metabolic health.
  • Further research is warranted to explore the long-term health consequences of this early-life difference in fat distribution.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
159
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.7K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
111
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
131
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
992
z Scores and Area Under the Curve01:17

z Scores and Area Under the Curve

z scores are the standardized values obtained after converting a normal distribution into a standard normal distribution. A z score is measured in units of the standard deviation. The z score tells you how many standard deviations the value x is above (to the right of) or below (to the left of) the mean, μ. Values of x that are larger than the mean have positive z scores, and values of x that are smaller than the mean have negative z scores. If x equals the mean, then x has a z score of...
17.1K